Bentley Systems (BSY) Reported the 13th Quarter of Double-Digit ARR Growth
In its second quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Bentley Systems, Incorporated (NASDAQ:BSY). Bentley Systems, Incorporated (NASDAQ:BSY) is an infrastructure engineering software solutions provider. The one-month return of Bentley Systems, Incorporated (NASDAQ:BSY) was 8.56%, and its shares gained 20.63% of their value over the last 52 weeks. On July 25, 2025, Bentley Systems, Incorporated (NASDAQ:BSY) stock closed at $58.59 per share, with a market capitalization of $17.775 billion.
Conestoga Capital Advisors stated the following regarding Bentley Systems, Incorporated (NASDAQ:BSY) in its second quarter 2025 investor letter:
"Bentley Systems, Incorporated (NASDAQ:BSY), a provider of infrastructure engineering software, outperformed the benchmark in 2Q, delivering its thirteenth consecutive quarter of double-digit annual recurring revenue growth (ARR). Management saw strength in Public Works, Utilities, and Small/Medium sized customers, as well as a resilient infrastructure spending environment, underpinned by the flow through in government funding (IIJA)."
A computer engineer in front of his screen monitoring a 3D model of a building, representing the company's open modeling and open simulation applications.
Bentley Systems, Incorporated (NASDAQ:BSY) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 38 hedge fund portfolios held Bentley Systems, Incorporated (NASDAQ:BSY) at the end of the first quarter compared to 35 in the previous quarter. Bentley Systems, Incorporated (NASDAQ: BSY) reported total revenues of $371 million for the first quarter, representing a 10% increase compared to the previous year and an 11% rise on a constant currency basis. While we acknowledge the potential of Bentley Systems, Incorporated (NASDAQ:BSY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In another article, we covered Bentley Systems, Incorporated (NASDAQ:BSY) and shared the list of AI news and ratings you probably missed. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Trump attacks ‘woke' Jaguar as carmaker names first Indian chief
Jaguar Land Rover has appointed its first Indian chief executive as Donald Trump accused the company of being in 'absolute turmoil' following a 'woke' marketing campaign. PB Balaji, chief financial officer at the the carmaker's Indian owners, Tata Motors, is to take up the post in November as Jaguar deals with the fallout of a rebrand in which it ditched its big cat logo and embraced a new hot pink aesthetic. On Monday, the US president contrasted the fortunes of Britain's Jaguar with American Eagle, a US clothing brand that recently saw its share price surge after debuting an advertising campaign with actress Sydney Sweeney. Mr Trump wrote on his Truth Social social media platform: 'Sydney Sweeney, a registered Republican, has the 'HOTTEST' ad out there. It's for American Eagle, and the jeans are 'flying off the shelves.' Go get 'em Sydney! 'On the other side of the ledger, Jaguar did a stupid, and seriously WOKE advertisement, THAT IS A TOTAL DISASTER! The CEO just resigned in disgrace, and the company is in absolute turmoil. Who wants to buy a Jaguar after looking at that disgraceful ad.' It comes days after Adrian Mardell, the 64-year-old boss of Jaguar Land Rover, announced his intention to retire. Under Mr Mardell, the car company sought to shake off its traditional image as a brand for 'Jag Men' and instead target a younger demographic. As part of plans to relaunch the brand, Jaguar last year debuted an advertising campaign depicting a bright pink, Mars-like landscape and catwalk models wearing unusual, brightly coloured clothing – but no car. The clip was widely mocked online. Jaguar has also ditched its jumping cat logo and last December debuted a 'Barbie pink' concept car at Miami Art Week. Credit: Jaguar Critics have accused Jaguar of abandoning its core customers. Nigel Farage, the Reform UK leader, accusing Jaguar of going 'absolutely bonkers … showing a bunch of weirdos'. He predicted that the carmaker would 'now go bust. And you know what? They deserve to'. The appointment of Mr Balaji marks the first time Tata Motors has appointed a Jaguar Land Rover leader from within its own ranks since buying the two distinguished British brands from Ford at the height of the financial crisis. Mr Balaji, a mechanical engineering graduate, has worked at Tata Motors for almost eight years and has overseen a turnaround at JLR's parent company. The company has long been a dominant player in the Indian car market but was loss-making when he arrived. Tata Motor's share price has soared around 270pc since he arrived. At Jaguar, Mr Balaji must oversee a make-or-break relaunch of the brand. New Jaguars are currently unavailable in the UK as the carmaker prepares to launch an all-electric range next year. On Monday, Mr Trump said that Jaguar should have 'learned a lesson from Bud Lite, which went Woke and essentially destroyed, in a short campaign, the Company.' Two years ago, Bud Lite enraged Right-wingers in America and saw its sales plummet after it used transgender influencer Dylan Mulvaney in its marketing. Mr Trump said on Truth Social: 'The tide has seriously turned – Being WOKE is for losers, being Republican is what you want to be.' His comments also came after it emerged that Ms Sweeney was a registered Republican. Records uncovered over the weekend show she registered with the party in June last year. Shares in American Eagle jumped 17pc after the president's endorsement. Jaguar Land Rover's sales dipped to £25.2bn for the year to March 31, down from £25.7bn a year earlier. The company said this was driven by 'the prioritisation of higher margin vehicles'. More recently, the company's business has been hugely disrupted by US tariffs. JLR's sales to the US were temporarily paused in April after Mr Trump announced a 25pc tariff on car imports. The British carmaker sells around 100,000 vehicles each year in the US and the trade war put some £6.5bn in sales at risk. The US-UK trade deal secured a 10pc tariff for the first 100,000 British vehicles exported, seen as predominantly benefitting JLR. Aston Martin has pushed for rules to stop the system becoming 'a JLR tariff agreement'. Last week, the company said: 'Adrian Mardell has expressed his desire to retire from JLR after three years as CEO and 35 years with the company.' Jaguar Land Rover has been approached for comment. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
PayPal Maintains its Huge FCF Guidance Despite a Q2 Drop - Is PYPL Stock Too Cheap?
PayPal Holdings (PYPL) reported that its Q2 free cash flow (FCF) fell 42% to just $656 million from $1.14 billion last year. However, it maintained guidance of between $6 and $7 billion FCF in 2025, on par with its 2024 $6.767 billion FCF. If that actually happens, PYPL stock could be undervalued. It could be worth over 30% more at $88.35 per share. This article will show why. More News from Barchart Chevron's Q2 Free Cash Flow Rises - CVX Stock Looks Cheap Option Volatility And Earnings Report For Aug 4 - 8 Coinbase (COIN) vs. Visa (V): Which One of These Stocks Flashing Unusual Options Activity Wins Out? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. PYPL is at $67.75 in midday trading on Monday, Aug. 4. That's about $10 below its pre-earnings peak of $77.98 on July 24. Moreover, PYPL is still well below its Jan. 30 peak of $89.57. Strong Margins Except for Free Cash Flow PayPal's revenue rose +5.1% YoY to $8.288 billion, which was slightly higher (+2.56%) than analysts' estimates of $8.081 billion. Moreover, most of its margins were flat or slightly higher, except for free cash flow (FCF). For example, its all-important take-rate (i.e., revenue / total payment volume (TPV) fell just 2 basis points to 1.87% from 1.89% last year. That means that with higher TPV volume, PayPal is still able to 'take' its traditional fees from customers. In addition, its transaction margin (TM) (i.e., TM/revenue) rose just slightly to 46.38% from 45.76% last year. (Note the company talks about TM dollars up 7%, but this does not compare TM against higher revenue.) However, PayPal's operating cash flow (OCF) fell 41.1% from $1.525 billion last year to just $898 million. The deck said that this was affected by shifts in working capital timing (remember OCF includes addbacks to net income, one of which is changes in net working capital). After slightly higher capex, this led to a 49% drop in free cash flow (FCF) from $1.368 billion to $692 million. Its adj. FCF was 42.5% lower at $656 million. However, PayPal implied in its guidance that this was a one-off dip. In other words, the net working capital movements that led to a dip in Q2 will balance out later in the year. It maintained its outlook on page 14 of its Q2 presentation deck from last year that FCF would range between $6 billion and $7 billion. That would be on par with its 2024 FCF of $6.767 billion. So, if that happens, could PYPL stock be undervalued here? Let's look at its FCF yield metrics. Setting a Price Target Using FCF Yield PayPal does not pay a dividend to shareholders. But, if it did, the payment would be funded by its free cash flow. Let's just assume that it eventually pays out 50% of FCF to shareholders. What would the stock be worth then? Here is how we can work that out. Using the company's guidance (see above), we could expect at least $6.5 billion in FCF this year. That represents 19.7% of analysts' estimates of $33.03 billion in revenue this year. Moreover, next year they are projecting $35.05 billion, so FCF could rise to: $35.05 billion x 0.197 = $6.9 billion FCF 2026 That implies that its FCF yield is 10.68% given its market cap today of $64.59 billion (according to Yahoo! Finance). If PayPal paid out 50% of that to shareholders, that would equal $3.45 billion, or a dividend yield of over 5%: $3.45 billion dividends / $64.59 billion mkt cap = 0.0534 = 5.34% div. yield potential However, this may be too high a yield, and the stock's market cap might rise to lower this yield. For example, Stock Analysis shows PayPal has generated $5.3 billion in trailing 12-month (TTM) FCF. So, its TTM FCF yield is lower than 10.68%: $5.292b TTM FCF / $64.59b mkt cap today = 0.0819 = 8.19% TTM FCF yield Therefore, if PayPal paid out 50% of its FCF as a dividend, the equivalent dividend should be 4.095%: $3.45b 2026 div / 0.04095 = $84.25 billion projected mtk cap That is 30.4% higher than today's market value of $64.59 billion. In other words, PYPL stock is potentially worth +30.4% more than today's price of $68.04: 67.75 x 1.304 = $88.35 target price Analysts Agree PYPL Stock is Undervalued Yahoo! Finance shows that 43 analysts covering PYPL have an average price target of $83.26. That's +22% higher than today's price. Similarly, Barchart's survey shows an average of $81.14. Similarly, Stock Analysis shows that 33 analysts have an average price target of $83.00. However, which tracks recent analyst recommendations, shows that 35 analysts have an average price target of $89.04. That is closer to my price target of $88.35 above. As a result, the average survey price target from analysts is $84.11, or +23.6% higher than today's price. The bottom line here is that either using a FCF analysis or just from analysts' target prices, PYPL stock looks to be too cheap. One way to play this is to sell short out-of-the-money (OTM) put options. That way, an investor can get paid while waiting to buy in at a lower price. Shorting OTM PYPL Put Options For example, look at the Sept. 5 expiration period, 32 days from now (days to expiry or DTE). The $65 strike price put option contract has a midpoint premium of $1.03. This strike perice is 4% below the trading price (i.e., out-of-the-money or OTM). That means a short-seller of this put contract makes an immediate yield of 1.585% (i.e., $1.03/$65.00 = 0.015846). The investor first secures $6,500 in cash or buying power with their brokerage firm. Then they enter an order to 'Sell to Open' 1 put contract at $65.00 for expiry on Sept. 5. The account will then immediately receive $103.00 (i.e., $1.03 x 100 shares since each put contract represents 100 shares). So, the $103.00 income represents 1.585% of the $6,500 secured as collateral. As long as PYPL stays over $65.00 on or before Sept. 5, the account will not be assigned to buy 100 shares at $65.00. But, even if this happens, the net breakeven buy-in is just $63.97 (i.e., $65.00-$1.03). That is 5.9% or more below today's price, so it provides good downside protection. More risk-averse investors can sell short the $64.00 strike price put contract and still receive $79 for an investment of $6,400. That represents a 1.234% one-month yield. Note that there is a slightly lower delta ratio, -22%, or a 22% chance that PYPL will fall to this strike price. That is based on historical volatility. The bottom line is that investors can set a lower buy-in by shorting OTM puts. Moreover, existing investors in PYPL can earn a pseudo dividend yield here. For example, if this 1.585% short-put one-month yield play can be repeated over 3 months, the expected return yield is 4.755%. That is higher than our expected 4.1% annual dividend yield if PayPal were to pay out 50% of its FCF next year (see above). The bottom line is that PYPL stock looks deeply undervalued here. One way to play it is to short OTM puts in nearby expiry periods. On the date of publication, Mark R. Hake, CFA did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
Woburn, MA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2025 on Wednesday, August 13, 2025. The results will be released after the market close on Wednesday, August 13 and the company will host a conference call on Thursday, August 14 at 10:00am Eastern Time. Conference Call and Webcast Information Event: Biofrontera Inc. Second Quarter 2025 Financial Results and Business Update Conference Call Date: Thursday, August 14, 2025 Time: 10:00am ET Conference Call: 1-877-877-1275 (U.S.)1-412-858-5202 (international) Webcast: Webcast | Second Quarter 2025 Financial Results and Business Update Conference Call About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz ® with the RhodoLED ® lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visit and follow Biofrontera on LinkedIn and X. Contacts:Investor RelationsAndrew Barwicki1-516-662-9461ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
